Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Igor Latorzeff

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|March 1, 2014
Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational studyThierry Lebret, Stéphane Culine, Jean-Louis Davin, et al.
Frontiers in Oncology|July 5, 2021
Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical ReviewPaul Sargos, Mame Daro Faye, Manon Bacci, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 17, 2025
Guidelines about radiotherapy and oncologic systemic treatments: Stop or continue?Chloé Buchalet, Constance Golfier, Jean-Christophe Faivre, et al.
Therapeutic Advances in Urology|December 2, 2014
Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: a French prospective observational studyThierry Lebret, Jean-Louis Davin, Christophe Hennequin, et al.
Plos One|January 26, 2019
Intensity-modulated radiotherapy for prostate cancer with seminal vesicle involvement (T3b): A multicentric retrospective analysisFlora Goupy, Stéphane Supiot, David Pasquier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2025
Reirradiation of prostate, gynaecologic and pelvic tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologiqueYuedan Zhou, Alexandre Escande, David Pasquier, et al.
Frontiers in Oncology|March 25, 2017
Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target ConceptFlorent Vilotte, Mickael Antoine, Maxime Bobin, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2025
Patterns of Relapse Following Radiation Therapy of Intermediate-Risk Prostate Cancer in the PROFIT Randomized TrialMartin Langé, Loïc Campion, Luc Ollivier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 28, 2025
External beam radiotherapy for prostatic cancers: 2025 updateIgor Latorzeff, Alizée Camps-Maléa, Christophe Hennequin, et al.
Neuro-Chirurgie|May 25, 2025
Changes in patient-perceived balance and vestibular function after Gamma-knife stereotactic radiosurgery for vestibular schwannoma: 12-month outcomes in a single-centre pilot studyNadia El Fassi, Yohan Gallois, Olivier Deguine, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|March 1, 2014
Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational studyThierry Lebret, Stéphane Culine, Jean-Louis Davin, et al.
Frontiers in Oncology|July 5, 2021
Late Gastrointestinal Tolerance After Prostate Radiotherapy: Is the Anal Canal the Culprit? A Narrative Critical ReviewPaul Sargos, Mame Daro Faye, Manon Bacci, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|October 17, 2025
Guidelines about radiotherapy and oncologic systemic treatments: Stop or continue?Chloé Buchalet, Constance Golfier, Jean-Christophe Faivre, et al.
Therapeutic Advances in Urology|December 2, 2014
Selection criteria for initiation and renewal of luteinizing hormone-releasing hormone agonist therapy in patients with prostate cancer: a French prospective observational studyThierry Lebret, Jean-Louis Davin, Christophe Hennequin, et al.
Plos One|January 26, 2019
Intensity-modulated radiotherapy for prostate cancer with seminal vesicle involvement (T3b): A multicentric retrospective analysisFlora Goupy, Stéphane Supiot, David Pasquier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 25, 2025
Reirradiation of prostate, gynaecologic and pelvic tumours, suggestions from the Recommendations Commission of the Société française de radiothérapie oncologiqueYuedan Zhou, Alexandre Escande, David Pasquier, et al.
Frontiers in Oncology|March 25, 2017
Post-Prostatectomy Image-Guided Radiotherapy: The Invisible Target ConceptFlorent Vilotte, Mickael Antoine, Maxime Bobin, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2025
Patterns of Relapse Following Radiation Therapy of Intermediate-Risk Prostate Cancer in the PROFIT Randomized TrialMartin Langé, Loïc Campion, Luc Ollivier, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 28, 2025
External beam radiotherapy for prostatic cancers: 2025 updateIgor Latorzeff, Alizée Camps-Maléa, Christophe Hennequin, et al.
Neuro-Chirurgie|May 25, 2025
Changes in patient-perceived balance and vestibular function after Gamma-knife stereotactic radiosurgery for vestibular schwannoma: 12-month outcomes in a single-centre pilot studyNadia El Fassi, Yohan Gallois, Olivier Deguine, et al.
Pageof 8